PLATINUM RESISTANT OVARIAN CANCER
Clinical trials for PLATINUM RESISTANT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM RESISTANT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM RESISTANT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for women with resistant ovarian cancer
Disease control OngoingThis study is testing whether adding an experimental drug called NP-G2-044 (Prilukae) to standard chemotherapy (PLD) works better than the standard chemo alone for women with platinum-resistant ovarian cancer. The goal is to find the best dose of the new combination and see if it…
Matched conditions: PLATINUM RESISTANT OVARIAN CANCER
Phase: PHASE2, PHASE3 • Sponsor: Novita Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Long-Acting cancer drug seeks to boost immune system against tumors
Disease control OngoingThis early-stage trial is testing a new long-acting immunotherapy drug called TransCon IL-2 β/γ in adults with advanced solid tumors that have spread or cannot be removed by surgery. The study aims to find safe doses and see if the drug, given alone or with other cancer treatment…
Matched conditions: PLATINUM RESISTANT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for women with aggressive ovarian cancer in global drug trial
Disease control OngoingThis global study is testing whether a new drug called Rina-S works better than current standard chemotherapy for women with platinum-resistant ovarian cancer. All 530 participants will receive active treatment—either Rina-S or one of four approved chemotherapy drugs—with a 50/50…
Matched conditions: PLATINUM RESISTANT OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC